Sol-Gel Technologies Partnered Generic Product Expected to Launch in the Second Quarter of 2021
NESS ZIONA, Israel, July 28, 2020 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on […]
NESS ZIONA, Israel, July 28, 2020 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on […]
SALT LAKE CITY, July 28, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and […]
Reports Record 2Q20 US GAAP Net Income of $112.1 million or $3.83 per shareRecord Economic Operating Income of $166.9 million, […]
CRANBURY, N.J., July 28, 2020 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a […]
SÃO PAULO, Brazil, July 28, 2020 (GLOBE NEWSWIRE) — XP Inc. (Nasdaq: XP), a leading, technology-driven financial services platform and […]
AUSTIN, Texas, July 28, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced the successful completion of […]
Next-generation PET tracer detects pathological alpha-synuclein with improved signal-to-noise ratioOral presentation at AAIC further demonstrates the strength of AC Immune’s […]
SOUTH SAN FRANCISCO, Calif., July 28, 2020 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused […]
Testing Experiencing Monthly Sequential ImprovementRecord Gross Margins of 63%SAN DIEGO, July 28, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an […]
– Ms. Thomson brings extensive strategic, transactional and intellectual property experience as Sierra prepares for potential transition into a commercial […]